Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath

NHS Blood and Transplant and Oxford University

United Kingdom

​

Expertise: Prof. Stanworth is a consultant hematologist and honorary senior clinical lecturer at the University of Oxford. His research centers on clinical indications of blood transfusion components through systematic reviews and clinical studies. Please view Prof. Stanworth’s publications here.

​

ICTMG connections:  Prof. Stanworth is the ICTMG executive chair (2021-present). He is co-chair of the Methods Committee, and a member of the Executive, Topics Selection, and Editorial committees. He is also the co-chair for the guideline development group for platelets.

Katerina Pavenski, MD, FRCPC
St. Michael's Hospital and University of Toronto
Canada

​

Expertise: Dr. Pavenski is clinical hematologist and head of the division of transfusion medicine at St. Michael’s Hospital in Toronto. She is an associate professor in the Departments of Laboratory Medicine & Pathobiology and Medicine, University of Toronto. Her research interests include clinical transfusion medicine, transfusion management of massive hemorrhage, and patient blood management. Please find Dr. Pavenski’s publications here.

​

ICTMG connections:  Dr. Pavenski is ICTMG executive vice-chair (2021-present).  She is co-chair of the Topics Selection Committee and a member of the Executive and the Dissemination and Implementation committees.  She is also a member of the guideline development group for platelets.

Arwa Z. Al-Riyami, BSc, MD, FRCPc, @DrRiyamia

Sultan Qaboos University Hospital and Sultan Qaboos University

Oman

​

Expertise: Dr. Al-Riyami is a senior consultant hematopathologist. Her research centres on transfusion & blood banking, cellular therapy, hematopathology and medical education & research.  Please view Dr. Al-Riyami's publications here.

​

ICTMG Connections:  Dr. Al-Riyami is a member of the Editorial & Dissemination Committee.

Melissa Brouwers, PhD

University of Ottawa

Canada

​

Expertise:  Dr. Brouwers is a health sciences researcher with an interest in knowledge translation, implementation science and evaluation and director of the School of Epidemiology and Public Health at the University of Ottawa. Please view Dr. Brouwers' publications here.

​

ICTMG connections:  Dr. Brouwers is a member of the Methods Committee

Jeannie Callum, MD, FRCPC, @JeannieCallum

Kingston Health Sciences Centre and Queen's University

Canada

​

Expertise:  Dr. Callum is a transfusion medicine specialist and hematologist. Her research investigates the management of major hemorrhage, transfusion-related errors, and adverse consequences of transfusion. Please view Dr. Callum's publications here.

​

ICTMG connections:  Dr. Callum is a member of the Dissemination and Implementation Committee, a member of the guideline development group for platelets, and the co-chair of the guideline development group for albumin.

James Daly, MBBS, FRACP, FRCPA

Australian Red Cross Lifeblood

Australia

​

Expertise:  Dr. Daly is a clinical and laboratory haematologist and medical director of pathology services at Australian Red Cross Lifeblood. Please view Dr. Daly's publications here.

​

ICTMG connections:  Dr. Daly is the co-chair of the Dissemination and Implementation Committee and a member of the Executive and the Editorial committees.

Greg Denomme, PhD, FCSMLS(D), @GregDenomme

Grifols Laboratory Solutions

United States

​

Expertise:  Dr. Denomme is a clinical and academic trained scientist. His research examines the molecular basis of blood group antigens and the application of molecular immunohematology in the diagnosis of immune-mediated hemolytic anemia. Please view Dr. Denomme’s publications here.

​

ICTMG connections:  Dr. Denomme is a member of the Topics Selection Committee, and a member of the guideline development group for hemoglobinopathies.

Lise Estcourt, MB BChir, MA(Cantab), MA(MEL), MSc, DLSHTM, DPhil, MRCP, FRCPath, @AndelLestcourt

National Health Service Blood & Transplant, University of Oxford, and Cochrane
United Kingdom

​

Expertise:  Prof. Estcourt is a consultant hematologist and associate professor at the University of Oxford. She is the medical director for transfusion for NHS Blood and Transplant, the medical director for the Systematic Review Initiative and a senior editor for Cochrane.  Her research includes clinical transfusion and component development. Please view Dr. Estcourt’s publications here.

​

ICTMG connections:  Prof. Escourt is a member of the Methods Committee, and a member of the guideline development group for platelets.

Dean Fergusson, PhD, MHA

Ottawa Hospital Research Institute
Canada

​

Expertise:  Dr. Fergusson is a senior scientist and director of the clinical epidemiology program at the Ottawa Hospital Research Institute. His clinical research interest are mainly in the field of transfusion medicine with a focus on transfusion alternatives and the effectiveness of blood products. Please view Dr. Fergusson’s publications here.  

​

ICTMG connections:  Dr. Fergusson is co-chair of the Methods Committee, and a member of the Executive and the Editorial committees. He is also a member of the guideline development group for platelets.

Mark Fung, MD, PhD, @MarkFungMDPhD

University of Vermont Medical Center
United States

​

Expertise:  Dr. Fung is a pathologist with expertise in transfusion medicine and HLA. His research interests include transfusion medicine/blood banking and HLA platelet compatibility. Please view Dr. Fung’s publications here.   

​

ICTMG connections:  Dr. Fung is the co-chair of the Editorial Committee, and a member of the Executive, Topics Selection, and Dissemination and Implementation committees.  He is also a member of the guideline development group for platelets.

Laura Green, MBBS, MRCP, FRCPath, MD (Res), FRCP

NHS Blood and Transplant and Queen Mary University of London
United Kingdom

​

Expertise:  Prof. Green is a consultant haematologist at NHS Blood and Transplant and a professor of haemostasis and transfusion medicine at Queen Mary University of London.  Her research focuses on improving transfusion management of bleeding patients.

​​

ICTMG connections:  Prof. Green is a member of the Editorial & Dissemination Committee.

Rachel Jug, MB, BCh, BAO

University of Cincinnati Medical Center
United States

​

Expertise:  Dr. Jug is an assistant professor of pathology and laboratory medicine with a research interest in transfusion medicine, anatomical and clinical pathology and medical education.

​

ICTMG connections:  Dr. Jug is a member of the Dissemination and Implementation and the Topics Selection Committee. She is a member of the Guideline Development Group for the platelet AGREE II systematic review.

Hyungsuk Kim, MSc, MD
Seoul National University Hospital and Seoul National University College of Medicine
Korea

​

Expertise:  Dr. Kim is a clinical pathologist, associate professor in laboratory medicine, and director of the hospital blood bank. His research interests include immunohematology, haemovigilance, and external quality assessment. He also works as the Director of Scientific Affairs of the Korean Society of Blood Transfusion and Executive Editor of the Korean Journal of Blood Transfusion. Please view Dr. Kim’s publications here. 

​

ICTMG connections:  Dr. Kim is a member of the Dissemination and Implementation Committee. 

Ursula La Rocca, MD, PhD
Italian National Blood Centre, National Institute of Health, and Sapienza University of Rome
Italy

​

Expertise: Dr. La Rocca is a hematologist with research interests in immunohematology and transfusion medicine, hematopoietic stem cell transplantation, and pediatric hematology.

​

ICTMG connections:  Dr. La Rocca is a member of the guideline development group for hemolytic disease of the newborn (HDN) and platelet transfusion. 

Lani Lieberman, MD, FRCP
University Health Network and Sunnybrook Health Science Centre
Canada

​

Expertise:  Dr. Lieberman is a transfusion medicine specialist and pediatric hematologist. Her research interests are transfusion medicine and benign hematology with a special interest in pediatric transfusion issues. 

​

ICTMG connections:  Dr. Lieberman is a member of the Topics Selection Committee, co-chair of the guideline development group for hemolytic disease of the newborn (HDN), and a member of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT). 

Vernon Louw, MBChB (Stell), MMed(Int Med)(Stell), PhD(HPE)(UFS)
Stellenbosh University
South Africa

​

Expertise:  Dr. Louw is a clinical hematologist and an executive head of department for medicine.  His research and teaching interests include transfusion medicine education.

​

ICTMG connections:  Dr. Louw is a member of the Topics Selection Committee and is a member for the guideline development group for platelets. 

Tadashi Matsushita, MD, PhD
Nagoya University Hospital
Japan

​​

Expertise:  Dr. Matsushita is a hematologist with a focus on clinical and basic research of blood coagulation and pathophysiology of thrombogenesis.

​

​

Susan Nahirniak, MD, @SusanNahirniak
Alberta Precision Laboratories and University of Alberta
Canada

​

Expertise: Dr. Nahirniak is a hematopathologist. Her research interests focus on improving the appropriateness and quality of transfusion medicine. Please find Dr. Nahirniak’s publications here.

​

ICTMG connections:  Dr. Nahirniak is a member of the Topics Selection and the Methods committees and is co-chair of the guideline development group for platelets.​​

Susan Robinson, MBBS, FRACP, FRCPA, GAICD

Guy's and St. Thomas' NHS Foundation Trust

United Kingdom

​

Expertise: Dr. Robinson is a consultant hematologist and clinical director. Her research interests include immunohematology, patient blood management, obstetric hematology and transfusion medicine. Please view Dr. Robinson’s publications here.

​

ICTMG connections:  Dr. Robinson is a member of the Topics Selection Committee, and a member of the guideline development groups for platelets and albumin.

Cynthia So-Osman, MD, PhD

Sanquin and Erasmus Medical Center

The Netherlands

​

Expertise: Dr. So-Osman is a clinical consultant in transfusion medicine and hematology. Her research interests include clinical transfusion medicine, blood management, and evidence-based medicine. Please view Dr. So-Osman’s publications  here.

​

ICTMG connections:  Dr. So-Osman is co-chair of the Dissemination and Implementation committee and a member of the Methods Committee.

Zbigniew M. Szczepiorkowski, MD, PhD

Dartmouth-Hitchcock Medical Center

United States

​

Expertise: Dr. Szczepiorkowski is professor of pathology and laboratory medicine, and medicine. His research interests include novel cellular therapies and an evidence-based approach to the use of therapeutic apheresis in clinical practice. Please view Dr. Szczepiorkowski’s publications here.

​

ICTMG connections:  Dr. Szczepiorkowski is the co-chair of the Editorial Committee, and a member of the Executive, the Methods and the Dissemination and Implementation committees. He is also a member of the guideline development group for platelets.​​

Aaron Tobian, MD, PhD

Johns Hopkins University 

United States

​

Expertise: Dr. Tobian is director of the transfusion medicine division and professor of pathology, medicine, oncology and epidemiology. His research interests include transfusion transmitted infections and HIV. Please view Dr. Tobian’s publications here.

​

ICTMG connections:  Dr. Tobian is a member of the Editorial and the Topics Selection committees, and is a member of the guideline development group for platelets.​​

Erica Wood, A0, MBBS, FRACP, FRCPA, FAHMS @ericawood.bsk.social

Monash University
Australia

​

Expertise: Dr. Wood is a transfusion medicine specialist and consultant hematologist. Her research interests include hemovigilance and patient blood management. She is a former president of the International Society of Blood Transfusion and the International Haemovigilance Network. Please view Dr. Wood’s publications here.

​

ICTMG connections:  Dr. wood a member of the Editorial & Dissemination Committee. She is also a member of the guideline development groups for hemolytic disease of the newborn (HDN) and platelets.

​